Clinical trial
Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
NCT01460641 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- July 31, 2018
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer